Baader Bank Aktiengesellschaft’s Bristol-Myers Squibb BMY Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-138,500	Closed	-$8.86M	–	343
2023 Q2	$8.86M	Hold	138,500	–	–	0.45%	89
2023 Q1	$9.6M	Sell	138,500 -138,500	-50%	-$9.77M	0.49%	77
2022 Q4	$20M	Buy	+277,000	New	+$20.9M	0.97%	28

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Baader Bank Aktiengesellschaft's BMY Position: Q2 2026 in Review

Baader Bank Aktiengesellschaft sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 7,452 shares — an estimated $439K sold.

Baader Bank Aktiengesellschaft first reported a position in BMY in Q4 2021 and held it in 16 quarters. The position peaked at $11.1M in Q3 2022. 922 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Baader Bank Aktiengesellschaft reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
Baader Bank Aktiengesellschaft sold 7,452 Bristol-Myers Squibb shares in Q2 2026, an estimated $439K.
Baader Bank Aktiengesellschaft first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 16 quarters.
Baader Bank Aktiengesellschaft's Bristol-Myers Squibb position peaked at $11.1M in Q3 2022.
922 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2026, filed 23 Jul 2026.